Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
No holdings reported for quarter Q3 2020 |
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
VANGUARD INTL EQUITY INDEX F | 19 | Q2 2019 | 92.7% |
TORTOISE ENERGY INFRSTRCTR C | 12 | Q3 2017 | 38.5% |
VANGUARD TAX MANAGED INTL FD | 10 | Q2 2019 | 76.4% |
VANGUARD INDEX FDS | 9 | Q2 2018 | 2.8% |
SPDR S&P 500 ETF TR | 8 | Q4 2017 | 4.2% |
WISDOMTREE TR | 7 | Q2 2016 | 6.1% |
KAYNE ANDERSON MLP INVT CO | 5 | Q4 2015 | 61.0% |
WISDOMTREE TR | 4 | Q2 2016 | 6.5% |
INNOVATE BIOPHARMACEUTICLS I | 4 | Q2 2019 | 0.5% |
OPHTHOTECH CORP | 3 | Q2 2015 | 3.1% |
View Hillview Capital Advisors, LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2019-08-01 |
13F-HR | 2019-05-13 |
13F-HR | 2019-02-01 |
13F-HR | 2018-10-23 |
13F-HR | 2018-07-25 |
13F-HR | 2018-04-30 |
13F-HR | 2018-02-02 |
13F-HR | 2017-11-13 |
13F-HR | 2017-07-27 |
13F-HR | 2017-05-15 |
View Hillview Capital Advisors, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.